Qualigen Therapeutics Announces Three Published Abstracts at American Association of Cancer Research Conference
March 22, 2022 09:15 ET
|
Qualigen Therapeutics, Inc.
Abstracts Review Positive In vivo Data and the Potential Mechanism of Action for QN-302 in Pancreatic and Prostate Cancers CARLSBAD, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Qualigen...